Floreasca Hospital is a major hospital in Bucharest, Romania. The hospital is specialized in providing emergency medical care.

There are 731 beds in Spitalul Clinic de Urgenta Bucuresti.

During the past decade, Spitalul Clinic de Urgenta Bucuresti conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic de Urgenta Bucuresti" #1 sponsor was "AO Clinical Investigation and Publishing Documentation" with 1 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored and "Novexel Inc" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic de Urgenta Bucuresti" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic de Urgenta Bucuresti" are "Coronary Artery Disease" (3 trials), "Acute Myocardial Infarction" (1 trials), "COPD" (1 trials), "Chronic Kidney Disease" (1 trials) and "Community Acquired Pneumonia" (1 trials). Many other conditions were trialed in "Spitalul Clinic de Urgenta Bucuresti" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic de Urgenta Bucuresti" are "Drug" (6 trials), "Behavioral" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "5% dextrose in water" (1 trials), "AD 237" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Gemcitabine (1000 mg/m2)" (1 trials) and "HX575 recombinant human erythropoietin alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic de Urgenta Bucuresti" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Clinic de Urgenta Bucuresti". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Spitalul Clinic de Urgenta Bucuresti, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic de Urgenta Bucuresti, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".